Pharma's Problem with Data Integrity | CPhI North America

CPhI North America is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

 

View, browse and sort the ever-growing list of sessions by pass type, track, and format. With this Session Scheduler, you can build your schedule in advance and access it during the show via export or with the Mobile App, once live. Sessions do fill up and seating is first come, first serve, so arrive early to sessions that you would like to attend.

Pharma's Problem with Data Integrity

Brian Nadel (Independent Consultant, EAS Consulting)

Location: E353c

Date: Wednesday, May 1

Time: 9:45am - 10:30am

Track: Drug Manufacturing

Vault Recording: TBD

The FDA takes data Integrity very seriously and their many Warning Letters and Import Alerts to dosage form and Active Pharmaceutical Ingredient (API) manufacturers in the past several years, indicate that validation is a consistent problem for the pharmaceutical industry. Data integrity- or a lack thereof - can have major repercussions for a firm as FDA expects that data be reliable and accurate. The crucial and often overlooked validation step can ultimately cost manufacturers untold amounts in R&D, materials, product recalls, submissions, and more.

EAS Independent Consultant, Brian Nadel, a former FDA compliance officer and investigator, will share his expertise and provide actionable steps to assess, improve and document data validation.

Key takeaways from this session:
• Regulatory agencies look to how data is generated and safeguarded as the main basis for quality inspections
• Data integrity must align with cGMP compliance standards and provide reliable evidence of the work the firm carries out
• Understanding that electronic data and the systems that generate and store that information are part of the data integrity landscape
• How to control Data Integrity issues commonly associated with Electronic Records

Presentation File

Pharmas_Problem_with_Data.pdf